Novo Nordisk Licenses Nanexa Drug-Delivery Technology in Deal Worth Up to €1.17 Billion
Novo Nordisk (NYSE:NVO) has agreed to license drug-delivery technology from Swedish biotechnology company Nanexa in an agreement potentially…
Browsing Tag